Bank Loans, MLPs Be...
Health Care: Drugs
Alkermes PLC (ALKS: NASDAQ)
$31.75 -0.23 | -0.72%
05/22/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with ALKS
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- UserInvestments
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- Usergterryburns
- Usermitetwo Portfolio 1
Latest ALKS Headlines from TheStreet
- Alkermes Stock Hits New 52-Week High (ALKS) 04.19.13 | 02:04 pm
- Cramer's 6 Stocks in 60 Seconds: LDK ALKS APA BBY UNP HFC (Update 1) 04.18.13 | 05:04 pm
- 3 Stocks Advancing The Health Care Sector 04.17.13 | 01:04 pm
- Three Cheers For Alkermes Running A Depression Study In The US of A 04.17.13 | 10:04 am
- Alkermes Stock Gaps Up On Today's Open (ALKS) 04.17.13 | 10:04 am
- Cramer's 6 Stocks in 60 Seconds: EA BTU ALKS SLB PEP SWN (Update 1) 03.26.13 | 05:03 pm
- Alkermes: A Biotech With Multiple Drivers
02.28.13 | 11:02 am - Cramer's Top Stock Picks: ARIA ALKS LINE KORS WFM 02.28.13 | 06:02 am
- 5 Health Care Stocks Triggering 'Buys' This Week 02.20.13 | 07:02 am
- Alkermes PLC Stock Upgraded (ALKS) 02.04.13 | 04:02 am
Press Releases for ALKS
- Alkermes’ Corporate Presentation To Be Webcast At Three Upcoming Conferences - Business Wire 02.19.13 | 04:02 pm
- Alkermes’ Corporate Presentation To Be Webcast At Two Upcoming Conferences - Business Wire 02.05.13 | 04:02 pm
- Alkermes Plc Reports Third Quarter Fiscal 2013 Financial Results - Business Wire 01.31.13 | 07:01 am
- Alkermes To Host Conference Call To Discuss Financial Results For Third Quarter Of Fiscal 2013 - Business Wire 01.24.13 | 04:01 pm
- Alkermes Announces Notice Of Allowance Of Key U.S. Patent For Aripiprazole Lauroxil, A New Schizophrenia Drug Candidate - Business Wire 01.03.13 | 07:01 am
- Alkermes Expands CNS Pipeline And Announces Positive Results From Phase 1 Study Of ALKS 3831, A Novel Antipsychotic Therapy For The Treatment Of Schizophrenia - Business Wire 01.03.13 | 07:01 am
- Alkermes’ Corporate Presentation To Be Webcast At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 04:01 pm
- Alkermes And Collaborators To Present Data From Three Ongoing Clinical Development Programs At Two Major Medical Meetings - Business Wire 12.03.12 | 07:12 am
- Alkermes’ Corporate Presentation To Be Webcast At Two Upcoming Conferences - Business Wire 11.07.12 | 04:11 pm
- Alkermes Plc Reports Second Quarter Fiscal 2013 Financial Results - Business Wire 11.01.12 | 07:11 am
Partner Headlines for ALKS
- Pre-Market Earnings Report for May 23, 2013 : TD, RL, HRL, DLTR, AAP, SIG, GME, PDCO, ALKS, BKE, TTC, AINV - NASDAQ 05.22.13 | 08:05 pm
- Stocks Reverse Early Gains; LinkedIn Gives Up 50-Day Line - Investor's Business Daily 05.22.13 | 03:05 pm
- The Week Ahead: Full Slate of Economic Data; Earnings From Cisco, Wal-Mart and Deere - Benzinga 05.10.13 | 09:05 pm
- Stocks Pull Back Late Session; Apple, Panera Earnings On Tap - Investor's Business Daily 04.23.13 | 03:04 pm
- Biotech Stocks Get A Turbo Boost From Vertex - Seeking Alpha 04.20.13 | 09:04 am
- Alkermes Leaps On Study Results, May Offer New Entry - Investor's Business Daily 04.17.13 | 05:04 pm
- Indexes Notch Sharp Declines; New 52-Week Low For Apple - Investor's Business Daily 04.17.13 | 04:04 pm
- Stocks Hold Near Lows, But Alkermes Soars To New High - Investor's Business Daily 04.17.13 | 03:04 pm
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- Pockets of Strength In Top Groups, Few Leaders Basing - Investor's Business Daily 04.15.13 | 06:04 pm
